Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Agios Pharmaceuticals Inc (NASDAQ:AGIO)

46.72
Delayed Data
As of 3:59pm ET
 -1.93 / -3.97%
Today’s Change
33.50
Today|||52-Week Range
67.98
-28.03%
Year-to-Date

Today’s Trading

Previous close48.65
Today’s open47.43
Day’s range45.73 - 48.22
Volume1,173,295
Average volume (3 months)736,729
Market cap$2.0B
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-98.11%
Earnings growth (this year)-57.64%
Earnings growth (next 5 years)--
Revenue growth (last year)-9.55%
P/E ratioNM
Price/Sales41.10
Price/Book5.31

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-3.64-6.54%
PRTAProthena Corporation...-2.83-5.05%
SRPTSarepta Therapeutics...-0.91-2.61%
LGNDLigand Pharmaceutica...-3.28-3.10%
Data as of 3:59pm ET, 12/07/2016

Financials

Next reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$1.41
Annual revenue (last year)$59.1M
Annual profit (last year)-$117.7M
Net profit margin-199.14%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
David Paul Schenkein
Chief Financial Officer
Andrew J. Hirsch
Corporate headquarters
Cambridge, Massachusetts

Forecasts


Search for Jobs